Search

everythinglearnresearchcommunity

for

Search:↓

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

The document concludes that transplantology has evolved with improved techniques and materials, making transplants more successful and expanding the types of transplants possible.

EF and PXE not closely related.

Men with early-onset hair loss have more heart disease risk factors.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

Polyphenols in plant foods help prevent diseases and have potential uses in food, cosmetics, and more.

People with androgenetic alopecia have a higher risk of heart disease.

Cubosomes improve drug delivery for skin and eye diseases by enhancing adhesion, retention, and release.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

High levels of HSP70 and IL-15 are linked to more severe alopecia areata.

PRP is an effective and safe treatment for alopecia areata.

The study found that the hair loss condition in Cesky Fousek dogs is influenced by multiple genes affecting skin and muscle structure, fat metabolism, and immunity.

Nonandrogenic factors like oxidative stress and microinflammation are important in hair loss progression.

Understanding the Y chromosome is key to male health, aging, and developing diagnostic tools.

N-oxides are important in medicine for improving drug properties and targeting.

CLEC4D gene variants may increase the risk of alopecia areata in Jordanians.

Genetic predictions of baldness in Europeans don't apply well to African men.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Zinc is important for skin health, and supplements can help treat various skin and hair disorders, but more research is needed for conditions like psoriasis and vitiligo.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

CRISPR/Cas9 gene-editing shows promise for improving sheep and goat breeding but faces challenges with efficiency and accuracy.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Hair loss from genetics and hormones can be treated with drugs or surgery.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.